The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I:
wherein
R
1
to R
6
are as defmed in the specification and pharmaceutically acceptable acid addition salts thereof. This class of compounds has high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
本发明涉及式I的芳基
异噁唑-4-基
咪唑衍
生物:其中R1至R6如规范中定义,并且其药用酸盐。这类化合物具有高亲和力和选择性结合到
GABA A α5受体结合位点,可能有助于作为认知增强剂或治疗认知障碍如阿尔茨海默病。